viewOcado Group PLC

M&S's strategy director, Melanie Smith, appointed CEO of JV with Ocado

Unless Waitrose plays ball, Ocado will not be able to start supplying M&S food until September of next year

Ocado Group PLC - M&S's strategy director, Melanie Smith, appointed CEO of JV with Ocado
"The new company will be able to offer customers even greater range, service, quality and value," said Tim Steiner, Ocado's CEO

Ocado Group PLC (LON:OCDO) said the creation of its joint venture with Marks and Spencer Group PLC (LON:MKS) has now completed.

The sale of 50% of Ocado Retail Limited to M&S has gone through, prompting a few managerial changes.

Ocado said Melanie Smith, currently the strategy director at M&S, has been appointed as chief executive officer of Ocado Retail Limited while Lawrence Hene, who is currently the interim managing director of Ocado Retail Limited, will hang around as deputy chief executive of the joint venture for a transitional period before he moves back into a senior role within the Ocado group.

Ocado Retail will not sell M&S products until 1 September 2020, unless Ocado Retail's current arrangements with Waitrose terminate sooner.

"I have always believed that M&S Food could and should be online,” declared Steve Rowe, the chief executive officer of Marks & Spencer.

“The addition of Ocado to our family of businesses marks M&S's first truly transformational step in shaping our future as a digital-first retailer, as we combine the magic of M&S food with Ocado's award-winning service to create a new and compelling proposition. Through its unique OSP [Ocado Smart Platform] technology, Ocado has developed the most cost-advantaged model in online grocery retail and our new partnership unlocks growth for M&S Food through an immediately profitable, scalable presence in the UK's fastest-growing grocery sales channel,” he added.


Quick facts: Ocado Group PLC

Price: 2895 GBX

Market: LSE
Market Cap: £216.32 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


IXICO plays 'pivotal role' after announcing £2m extension to Huntington's...

IXICO PLC's (LON:IXI) Lammert Albert talks to Proactive London about the £2m extension to a contract to provide additional imaging services for a pivotal Huntington's disease (HD) study. Albert describes this as a 'strong suit' having started very early and now carrying out a Phase III study...

1 hour, 22 minutes ago

2 min read